These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22373875)

  • 1. Complement anaphylatoxin C3a as a novel independent prognostic marker in heart failure.
    Gombos T; Förhécz Z; Pozsonyi Z; Széplaki G; Kunde J; Füst G; Jánoskuti L; Karádi I; Prohászka Z
    Clin Res Cardiol; 2012 Aug; 101(8):607-15. PubMed ID: 22373875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement Components sC5b-9 and CH50 Predict Prognosis in Heart Failure Patients Combined With Hypertension.
    Wang W; Cai D
    Am J Hypertens; 2020 Jan; 33(1):53-60. PubMed ID: 31429866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation products in acute heart failure: Potential role in pathophysiology, responses to treatment and impacts on long-term survival.
    Trendelenburg M; Stallone F; Pershyna K; Eisenhut T; Twerenbold R; Wildi K; Dubler D; Schirmbeck L; Puelacher C; Rubini Gimenez M; Sabti Z; Osswald L; Breidthardt T; Müller C
    Eur Heart J Acute Cardiovasc Care; 2018 Jun; 7(4):348-357. PubMed ID: 29064269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaphylatoxin and terminal complement complexes in red cell salvage.
    Bengtsson A; Lisander B
    Acta Anaesthesiol Scand; 1990 Jul; 34(5):339-41. PubMed ID: 2389647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiography and complement activation. Evidence for generation of C3a anaphylatoxin by intravascular contrast agents.
    Westaby S; Dawson P; Turner MW; Pridie RB
    Cardiovasc Res; 1985 Feb; 19(2):85-8. PubMed ID: 3872180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaphylatoxin generation in multisystem organ failure.
    Heideman M; Hugli TE
    J Trauma; 1984 Dec; 24(12):1038-43. PubMed ID: 6334754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease.
    Gardinali M; Padalino P; Vesconi S; Calcagno A; Ciappellano S; Conciato L; Chiara O; Agostoni A; Nespoli A
    Arch Surg; 1992 Oct; 127(10):1219-24. PubMed ID: 1417490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered concentrations of terminal complement complexes, anaphylatoxins, and leukotrienes in the coronary sinus during cardiopulmonary bypass.
    Bengtson A; Millocco I; Heideman M; Berggren H
    J Cardiothorac Anesth; 1989 Jun; 3(3):305-10. PubMed ID: 2520655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis.
    Hopkins P; Belmont HM; Buyon J; Philips M; Weissmann G; Abramson SB
    Arthritis Rheum; 1988 May; 31(5):632-41. PubMed ID: 3259882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis.
    Hack CE; Nuijens JH; Felt-Bersma RJ; Schreuder WO; Eerenberg-Belmer AJ; Paardekooper J; Bronsveld W; Thijs LG
    Am J Med; 1989 Jan; 86(1):20-6. PubMed ID: 2783358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.
    Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W
    Front Immunol; 2021; 12():668725. PubMed ID: 34276659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement C3a predicts outcome in cardiac resynchronization therapy of heart failure.
    Széplaki G; Boros AM; Szilágyi S; Osztheimer I; Jenei Z; Kosztin A; Nagy KV; Karády J; Molnár L; Tahin T; Zima E; Gellér L; Prohászka Z; Merkely B
    Inflamm Res; 2016 Dec; 65(12):933-940. PubMed ID: 27492980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of ficolin-3 with severity and outcome of chronic heart failure.
    Prohászka Z; Munthe-Fog L; Ueland T; Gombos T; Yndestad A; Förhécz Z; Skjoedt MO; Pozsonyi Z; Gustavsen A; Jánoskuti L; Karádi I; Gullestad L; Dahl CP; Askevold ET; Füst G; Aukrust P; Mollnes TE; Garred P
    PLoS One; 2013; 8(4):e60976. PubMed ID: 23596511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
    Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
    Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-evaluation of the storage conditions for blood samples which are used for determination of complement activation.
    Stöve S; Klos A; Bautsch W; Köhl J
    J Immunol Methods; 1995 May; 182(1):1-5. PubMed ID: 7769237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbohydrate antigen-125 and N-terminal pro-brain natriuretic peptide levels: compared in heart-failure prognostication.
    Ordu S; Ozhan H; Alemdar R; Aydin M; Caglar O; Yuksel H; Kandis H
    Tex Heart Inst J; 2012; 39(1):30-5. PubMed ID: 22412224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylatoxin levels in human aqueous humor.
    Mondino BJ; Sumner H
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction: A Holistic Proteomic Approach.
    Hage C; Michaëlsson E; Linde C; Donal E; Daubert JC; Gan LM; Lund LH
    Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction.
    Salah K; Stienen S; Pinto YM; Eurlings LW; Metra M; Bayes-Genis A; Verdiani V; Tijssen JGP; Kok WE
    Heart; 2019 Aug; 105(15):1182-1189. PubMed ID: 30962192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.